Please provide your email address to receive an email when new articles are posted on . Researchers in Japan found that a stool color card screening was effective in detecting biliary atresia in ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings.

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...

Of the 9989 participants who could be evaluated, 65 (0.7%) had colorectal cancer and 757 (7.6%) had advanced precancerous lesions (advanced adenomas or sessile serrated polyps measuring ≥1 cm in the ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

A multitarget stool DNA test detected more colorectal cancers (CRCs) than other testing but also resulted in more false-positives, according to a new study. “Despite the supporting evidence, ...

Cologuard stool DNA testing for colorectal cancer was found to be an accurate noninvasive screening option for Alaska Native people, a population with one of world's highest rates of colorectal cancer ...

A calprotectin stool test detects levels of calprotectin in stool. This protein indicates bowel inflammation. It can help diagnose and monitor conditions such as inflammatory bowel disease (IBD). A ...

A stool ova and parasite, or O&P, test is a simple way of diagnosing parasite infections. This test determines whether parasites and their eggs are present in your stool. The stool O&P test is a ...

Overall, though, the researchers concluded that further evaluation is needed. In an accompanying editorial, Douglas J. Robertson, MD, MPH, of the White River Junction Veterans Affairs Medical Center ...